CPRT vs NVAX · P/E 19, rev $3.51B vs P/E 2.5, rev $196.2M
Copart Inc (CPRT) versus Novavax Inc (NVAX) — a side-by-side from cached financials, not a winner call.
Copart Inc (CPRT) is a specialty business services company listed on US.
Novavax Inc (NVAX) is a biotechnology company listed on US.
Latest reported CPRT revenue for 2026-04-30 was $3.51B. Net income was $1.16B. Revenue was up 54.3% from 2026-01-31 to 2026-04-30. CPRT currently screens at market cap $28.66B and trailing P/E 19.2.
Latest reported NVAX revenue for 2026-06-30 was $196.2M. Net income was -$62.9M. Revenue was up 40.6% from 2026-03-31 to 2026-06-30. NVAX currently screens at market cap $1.09B and trailing P/E 2.5.
CPRT currently screens at market cap $28.66B and trailing P/E 19.2. NVAX currently screens at market cap $1.09B and trailing P/E 2.5.
Not investment advice. Open the CPRT and NVAX stock pages for the full models.
Not investment advice.